Cargando…
BDNF provides many routes toward STN DBS‐mediated disease modification
The concept that subthalamic nucleus deep brain stimulation (STN DBS) may be disease modifying in Parkinson's disease (PD) is controversial. Several clinical trials that enrolled subjects with late‐stage PD have come to disparate conclusions on this matter. In contrast, some clinical studies in...
Autores principales: | Fischer, D. Luke, Sortwell, Caryl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587505/ https://www.ncbi.nlm.nih.gov/pubmed/30440081 http://dx.doi.org/10.1002/mds.27535 |
Ejemplares similares
-
Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS
por: Miller, Kathryn M., et al.
Publicado: (2021) -
Rescue GPi-DBS for a Stroke-associated Hemiballism in a Patient with STN-DBS
por: Oyama, Genko, et al.
Publicado: (2014) -
STN-DBS Reduces Saccadic Hypometria but Not Visuospatial Bias in Parkinson's Disease Patients
por: Fischer, Petra, et al.
Publicado: (2016) -
STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
por: Huotarinen, Antti, et al.
Publicado: (2017) -
Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action Tremor
por: Parihar, Raminder, et al.
Publicado: (2015)